Exploration of Pregnant Women's Reluctance Toward COVID-19 Vaccination
- Conditions
- Vaccinate Against Covid-19Reluctance Pregnant Women's
- Registration Number
- NCT06968117
- Lead Sponsor
- Centre Hospitalier de Gonesse
- Brief Summary
This study aims to explore the reasons behind the reluctance of pregnant women to get vaccinated against COVID-19. With the ongoing pandemic, it has become essential to understand the concerns that women have regarding the COVID-19 vaccine, especially during pregnancy. Pregnant women are at a higher risk of severe complications from COVID-19, including premature birth, preeclampsia, and the need for intensive care.The goal of this research is to identify the barriers that prevent pregnant women from getting vaccinated, whether they are based on fears, misconceptions, or a lack of information. By understanding these concerns, healthcare providers can have better conversations with their patients and provide accurate, evidence-based information to help them make informed decisions about their health and the health of their unborn child.Through interviews and visual methods, the study seeks to gather valuable insights into the emotional and psychological aspects of vaccine hesitancy among pregnant women. These findings will help develop a tool to assist healthcare providers in addressing vaccine hesitancy effectively, ensuring that women are given all the necessary information to make the best decision for their health and the well-being of their baby.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 15
- During pregnancy follow-up consultations,
- Following their visit to the Gynecology-Obstetrics emergency department, regardless of the reason,
- Hospitalized in the diabetology department or in the high-risk pregnancy (HRP) or postpartum care department.
- The patient is over 18 years old
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rate of vaccine hesitancy among pregnant women, assessed through a standardized questionnaire. January 2021-April 2023
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
France
🇫🇷Gonesse, France
France🇫🇷Gonesse, France